DEDHAM, Mass., Oct. 15 /PRNewswire/ -- Cortek, Inc. continues to expand its product offering with the introduction of the Chorus(TM) Cervical Allograft System. The allograft is a cortical construct with lordotic angulation offering maximum compressive strength while re-establishing sagittal alignment. A simplified instrument system has been developed which provides accurate sizing and precise placement of this new graft.
With the addition of the Chorus implant, Cortek is able to offer a full spectrum of cervical allografts providing the physician with multiple options to treat varying patient requirements. Cortek(R) currently markets the Connect(TM) Cervical Allograft System the Solo(TM) Cervical Allograft, and a Dense Cancellous Allograft.
Dr. Mark Lonstein from Sarasota Memorial Hospital located in Florida said, "The implant's precise design and size offering allows for predictable intraoperative results. The simplified instrument system is easy to use and will minimize procedure time while providing consistent results. I have been very satisfied with the results I'm seeing in my cases using the Chorus Allograft."
Cortek, Inc. develops and markets advanced spinal products used to accelerate and improve lumbar and cervical repair while reducing patient cost in the treatment of chronic back pain. Cortek currently markets allografts and proprietary instrument systems for anterior lumbar interbody fusion (ALIF), posterior lumbar interbody fusion (PLIF), and cervical fusion procedures.
For further information, please contact Larry Jasinski at Cortek, Inc. or visit our website at http://www.cortekinc.com/.
CONTACT: Jodi Gricci of Cortek, Inc., 508-801-8139